Valuation eFFECTOR Therapeutics, Inc.

Stocks

Market Closed - OTC Markets 18:33:11 29/05/2026 +04			5-day change	1st Jan Change
0.000600 ^USD	+20.00%		-25.00%	+200.00%

11/09/24	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
08/07/24	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	16/03/22	08/03/23	26/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EFFECTOR THERAPEUTICS, INC.	-	-	-	-	940
WUXI APPTEC CO., LTD.	16.87x	6.34x	12.15x	1.77%	63.77B
ARGENX SE	30.14x	8.25x	27.02x	0.04%	56.37B
LONZA GROUP AG	37.48x	6.65x	19.86x	0.86%	54.62B
IQVIA HOLDINGS INC.	34.85x	3.31x	14.29x	-.--%	44.06B
BEONE MEDICINES AG	48.85x	5.63x	30.81x	-.--%	42.11B
REVOLUTION MEDICINES, INC.	-19.86x	192.36x	-21.16x	-.--%	41B
GENMAB A/S	47.33x	8.41x	28.18x	-.--%	34.92B
CELLTRION, INC.	32x	8.13x	21.15x	0.41%	32.82B
INSMED INCORPORATED	-71.62x	13.03x	-68.47x	-.--%	24.7B
Average	17.34x	28.01x	7.09x	0.34%	39.43B
Weighted average by Cap.	21.64x	26.34x	11.23x	0.45%